Difficult-to-culture (Fastidious)
Beneficial Strains
Pathogenic Strains
Functional Gene Discovery
Disease & Metabolic Pathway Prediction
Mechanism of Action (MoA) Identification
Functional Expansion
Microbiome DB & Genome-based Matching
Commercialization of First-in-class innovative drugs
(Licensing & Commercialization with Global Big Pharma)
Development of premium medifood through human clinical trials
Validation through preclinical research
Discovery of candidate functional materials
using the Pangenome Miner™ platform